Table 1 Baseline, treatment, and outcome characteristics stratified by < 8.7% and ≥ 8.7% edema quantification difference.
Low edema underestimation (N = 35) | High edema underestimation (N = 35) | p value | |
|---|---|---|---|
Baseline characteristics | |||
Female sex, n (%) | 15 (42.9) | 23 (65.7) | 0.055 |
Age, mean (SD) | 73.94 (10.18) | 77.31 (10.79) | 0.108 |
HbA1c, mean (SD) | 5.97 (0.86) | 5.98 (0.43) | 0.342 |
Admission NIHSS, median (IQR) | 15 (11.00–17.50) | 13 (7.00–17.50) | 0.420 |
Admission mRS, median (IQR) | 5 (4–5) | 4 (3–5) | 0.183 |
Admission ASPECTS, median (IQR) | 8 (7–9) | 8 (7–9) | 0.976 |
Treatment characteristics | |||
Successful recanalisation, n (%) | 26 (74.3) | 32 (91.4) | 0.057 |
Time admission CT to flow restoration, median (IQR) | 119 (95–147) | 105 (81–138) | 0.123 |
Time from symptom onset to flow restoration, median (IQR) | 372 (335–593) | 289 (225–343) | 0.019 |
Time flow restoration to FU CT, median (IQR) | 1208 (997–1514) | 1263 (985–1439) | 0.868 |
Administration of intravenous thrombolysis, n (%) | 16 (45.7) | 21 (60.0) | 0.231 |
Outcome characteristics | |||
Discharge NIHSS, median (IQR) | 5.00 (1.00, 16.50) | 5.00 (2.00, 14.00) | 0.919 |
Discharge mRS, median (IQR) | 3.00 (1.00, 5.00) | 3.00 (2.00, 5.00) | 0.870 |
